Pharmacologie du récepteur aux ions calcium extracellulaires. [Pharmacology of the extracellular calcium ion receptor] - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Thérapie Année : 2003

Pharmacologie du récepteur aux ions calcium extracellulaires. [Pharmacology of the extracellular calcium ion receptor]

Résumé

The calcium sensing receptor (CaSR) belongs to family 3 of G-protein coupled receptors. The CaSR, expressed at the surface of the parathyroid cells, controls parathyroid hormone (PTH) secretion and is the main regulator of calcium homeostasis. Its activity is regulated by small changes in the physiological concentrations of calcium and magnesium ions present in the serum and extracellular fluids, leading to the stimulation of the phospholipases C and A2. Molecules that potentiate the effect of extracellular calcium are called calcimimetics. They reduce the PTH level in vivo and have been proposed to be of therapeutic benefit for the treatment of both primary and secondary hyperparathyroidism. The blocking of CaSR by a calcilytic molecule results in the increase in serum PTH and might be of interest in the treatment of osteoporosis. The CaSR is also expressed in the thyroid, kidney, bone and in neuronal and glial cell populations, where it should be involved in the complex responses associated with calcium and magnesium ions present in the extracellular fluids.
Fichier non déposé

Dates et versions

hal-00173003 , version 1 (18-09-2007)

Identifiants

  • HAL Id : hal-00173003 , version 1
  • PUBMED : 14682186

Citer

Martial Ruat. Pharmacologie du récepteur aux ions calcium extracellulaires. [Pharmacology of the extracellular calcium ion receptor]. Thérapie, 2003, 58 (5), pp.395-401. ⟨hal-00173003⟩

Collections

CNRS NBCM
18 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More